DRRX
DURECT Corporation - Common Stock (DRRX)
$62
About DURECT Corporation - Common Stock (DRRX)
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Details
Daily high
$0.65
Daily low
$0.59
Price at open
$0.62
52 Week High
$1.84
52 Week Low
$0.48
Market cap
19.9M
Dividend yield
0.00%
Volume
59,309
Avg. volume
124,724
P/E ratio
-1.25
DURECT Corporation - Common Stock News
Details
Daily high
$0.65
Daily low
$0.59
Price at open
$0.62
52 Week High
$1.84
52 Week Low
$0.48
Market cap
19.9M
Dividend yield
0.00%
Volume
59,309
Avg. volume
124,724
P/E ratio
-1.25